Psychedelics continue to gradually gain support as an alternative therapeutic for various mental health conditions. A division of Magellan Health lended its voice to the issue in a new report calling for “fair and balanced” reviews for psychedelics to come to market. The report was published by Magellan Rx Management, a pharmacy benefits division of […]
Investors bullish on the impact psychedelics could have in behavioral health treatment now have the opportunity to put their money where their mouth is. A new company focused on making equity investments in psychedelics-related companies just debuted, giving stakeholders an interesting case study to follow in months to come. The company in question is Origin […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
